ORGO
NASDAQ · Biotechnology
Organogenesis Holdings Inc
$2.49
+0.05 (+2.05%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+235.3% upside
Low Target
$5.30
Average Target
$8.35
High Target
$10.56
Current Price
$2.49
Current
$2.49
$2.49
Target
$8.35
$8.35
$5.30
$8.35 avg
$10.56
Scenario Analysis
Bear Case
$5.30
112.9%
Low target
Base Case
$8.35
+235.3%
Avg target
Bull Case
$10.56
+324.1%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$7.08
-64.8% from high
52-Week Low
$2.61
+-4.6% from low
Target vs 52W High
$8.35
+18.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |